Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eyal Banin

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Molecular Vision|August 12, 2015
Nonsyndromic retinitis pigmentosa is highly prevalent in the Jerusalem region with a high frequency of founder mutationsDror Sharon, Eyal Banin
The Israel Medical Association Journal : IMAJ|March 21, 2006
Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanismsEdward Averbukh, Eyal Banin
Harefuah|June 12, 2004
[Experimental therapeutic modalities for retinitis pigmentosa]Eyal Banin, Itay Chowers
Harefuah|May 21, 2003
[Experimental therapeutic modalities for retinitis pigmentosa]Itay Chowers, Eyal Banin
Ophthalmology|November 5, 2013
Recognizing the KCNV2-related retinal phenotype. Author replyDror Sharon, Lina Zelnger, Eyal Banin
Advances in Experimental Medicine and Biology|July 13, 2023
Exonic Variants that Affect Splicing - An Opportunity for "Hidden" Mutations Causing Inherited Retinal DiseasesYogapriya Sundaresan, Eyal Banin, Dror Sharon
Cold Spring Harbor Perspectives in Medicine|September 11, 2023
Current Status of Clinical Trials Design and Outcomes in Retinal Gene TherapyBoris Rosin, Eyal Banin, Jose-Alain Sahel
Medical Hypotheses|April 15, 2004
A two-compartment model of the human retinaStefan Sisak, Eyal Banin, Eytan Z Blumenthal
Advances in Experimental Medicine and Biology|April 13, 2021
Cell-Based Therapies for Age-Related Macular DegenerationSamer Khateb, Shekhar Jha, Kapil Bharti, et al.
Advances in Experimental Medicine and Biology|July 13, 2023
Morphological and Functional Comparison of Mice Models for Retinitis PigmentosaPrakadeeswari Gopalakrishnan, Avigail Beryozkin, Eyal Banin, et al.
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Molecular Vision|August 12, 2015
Nonsyndromic retinitis pigmentosa is highly prevalent in the Jerusalem region with a high frequency of founder mutationsDror Sharon, Eyal Banin
The Israel Medical Association Journal : IMAJ|March 21, 2006
Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanismsEdward Averbukh, Eyal Banin
Harefuah|June 12, 2004
[Experimental therapeutic modalities for retinitis pigmentosa]Eyal Banin, Itay Chowers
Harefuah|May 21, 2003
[Experimental therapeutic modalities for retinitis pigmentosa]Itay Chowers, Eyal Banin
Ophthalmology|November 5, 2013
Recognizing the KCNV2-related retinal phenotype. Author replyDror Sharon, Lina Zelnger, Eyal Banin
Advances in Experimental Medicine and Biology|July 13, 2023
Exonic Variants that Affect Splicing - An Opportunity for "Hidden" Mutations Causing Inherited Retinal DiseasesYogapriya Sundaresan, Eyal Banin, Dror Sharon
Cold Spring Harbor Perspectives in Medicine|September 11, 2023
Current Status of Clinical Trials Design and Outcomes in Retinal Gene TherapyBoris Rosin, Eyal Banin, Jose-Alain Sahel
Medical Hypotheses|April 15, 2004
A two-compartment model of the human retinaStefan Sisak, Eyal Banin, Eytan Z Blumenthal
Advances in Experimental Medicine and Biology|April 13, 2021
Cell-Based Therapies for Age-Related Macular DegenerationSamer Khateb, Shekhar Jha, Kapil Bharti, et al.
Advances in Experimental Medicine and Biology|July 13, 2023
Morphological and Functional Comparison of Mice Models for Retinitis PigmentosaPrakadeeswari Gopalakrishnan, Avigail Beryozkin, Eyal Banin, et al.
Pageof 19